HPV16 E6-Activated OCT4 Promotes Cervical Cancer Progression by Suppressing p53 Expression via Co-Repressor NCOR1

Shujuan Shu(Women's Hospital, School of Medicine, Zhejiang University), Weiguo Lv(Women's Hospital, School of Medicine, Zhejiang University)

Frontiers in Oncology

July 7, 2022

10.3389/fonc.2022.900856

Cited by 25

Related Papers

Synergistic combination of histone deacetylase inhibitor suberoylanilide hydroxamic acid and oncolytic adenovirus ZD55-TRAIL as a therapy against cervical cancer

|Molecular Medicine Reports|2012|11